US Broker Ratings

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling an 18% Potential Upside Amid Robust Analyst Ratings

In the dynamic landscape of the biotechnology industry, Royalty Pharma plc (NASDAQ: RPRX) stands out with its unique business model and promising growth prospects. With a..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 21.60% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. healthcare sector, has piqued investor interest with its diversified operations across hospital and ambulatory care..

Exelixis, Inc. (EXEL) Stock Analysis: Unpacking the 5.86% Potential Upside in Biotechnology

As investors navigate the dynamic landscape of biotech stocks, Exelixis, Inc. (NASDAQ: EXEL) commands attention with its robust market cap of $11.44 billion and a promising..

Tempus AI, Inc. (TEM) Stock Analysis: Uncovering a 28.40% Upside in the Healthcare Tech Space

Tempus AI, Inc. (TEM) is carving a niche in the healthcare technology sector, where it operates as a premier provider of next-generation sequencing diagnostics and advanced..

AbbVie Inc. (ABBV) Investor Outlook: Navigating a Robust Market Cap with Potential Upside

AbbVie Inc. (NYSE: ABBV), a stalwart in the healthcare sector, commands a significant presence in the drug manufacturing industry. With a market capitalization of $417.6 billion,..

Insmed Incorporated (INSM) Stock Analysis: Navigating Biotech Potential with a 7.73% Upside

Insmed Incorporated (NASDAQ: INSM), a notable player in the biotechnology sector, is capturing the attention of investors with its strategic focus on developing therapies for serious..

Encompass Health Corporation (EHC): Investor Outlook on a Robust 22.72% Potential Upside

Encompass Health Corporation (EHC), a leading player in the healthcare sector, continues to capture investor attention with its impressive growth metrics and robust analyst ratings. With..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: 23% Upside Potential Amid Strong Buy Ratings

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, specializes in developing pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders. With a market capitalization of..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Unpacking a 13% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands out in the biotechnology sector with its impressive market cap of $109.42 billion and a robust portfolio targeting cystic fibrosis..

Danaher Corporation (DHR) Stock Analysis: Exploring an 11.79% Potential Upside Amidst Robust Buy Ratings

Danaher Corporation (NYSE: DHR) continues to capture the attention of investors in the healthcare sector, particularly within the diagnostics and research industry. With a substantial market..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Strong Growth Trajectory and Analyst Confidence

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is making waves in the biotechnology sector with its innovative approach to therapeutics based on ribonucleic acid interference (RNAi). As the..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Balancing Potential Upside of 96% with Current Challenges

Investors in the biotechnology sector are no strangers to volatility, but the current landscape for Summit Therapeutics Inc. (NASDAQ: SMMT) presents a unique mix of opportunity..

Medtronic plc (MDT) Stock Analysis: Navigating a Strong Portfolio with an 8.51% Upside Potential

Medtronic plc (NYSE: MDT) stands as a prominent entity in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $129.8..

Humana Inc. (HUM) Stock Analysis: Potential Upside of 26.78% Captures Investor Attention

Humana Inc. (NYSE: HUM), a stalwart in the healthcare sector with a market capitalization of $27.31 billion, is gaining attention from investors due to its promising..

Centene Corporation (CNC) Stock Analysis: Exploring a 9.43% Potential Upside in the Healthcare Sector

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, is capturing investor attention with its promising 9.43% potential upside, as indicated by analysts’..

DexCom, Inc. (DXCM) Investor Outlook: A 41% Potential Upside Amid Innovative Diabetes Solutions

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the medical devices sector, has established itself as a leader in continuous glucose monitoring (CGM) systems, catering to..

Investor Outlook: The Cooper Companies, Inc. (COO) Eyes Nearly 10% Upside Potential

The Cooper Companies, Inc. (NYSE: COO), a significant player in the healthcare sector, particularly in medical instruments and supplies, presents a compelling opportunity for investors eyeing..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Look at Potential Upside and Strong Revenue Growth

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a formidable player in the healthcare sector, specializing in both specialty and generic drug manufacturing. With its headquarters..

Boston Scientific Corporation (BSX) Investor Outlook: Evaluating a 30% Upside Potential Amidst Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $143.62..

Quest Diagnostics (DGX) Stock Analysis: Navigating the Strong Revenue Growth and Strategic Market Position

Quest Diagnostics Incorporated (NYSE: DGX) stands as a robust player within the healthcare sector, specifically in the diagnostics and research industry. With a significant market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds